These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37970284)
1. Adult Onset Episodic Encephalopathy Due to Citrin Deficiency-A Case Report. Baskar D; Lakshmi V; Nalini A; Arunachal G; Bhat MD; Nanjaiah ND; Yadav R; Chowdary R; Raja P; Mounika A; Sharath PS; Vengalil S Ann Indian Acad Neurol; 2023; 26(4):553-555. PubMed ID: 37970284 [TBL] [Abstract][Full Text] [Related]
2. Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia. Hayasaka K; Numakura C; Toyota K; Kakizaki S; Watanabe H; Haga H; Takahashi H; Takahashi Y; Kaneko M; Yamakawa M; Nunoi H; Kato T; Ueno Y; Mori M Mol Genet Metab Rep; 2014; 1():42-50. PubMed ID: 27896073 [TBL] [Abstract][Full Text] [Related]
3. Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia. Hayasaka K; Numakura C; Yamakawa M; Mitsui T; Watanabe H; Haga H; Yazaki M; Ohira H; Ochiai Y; Tahara T; Nakahara T; Yamashiki N; Nakayama T; Kon T; Mitsubuchi H; Yoshida H J Inherit Metab Dis; 2018 Sep; 41(5):777-784. PubMed ID: 29651749 [TBL] [Abstract][Full Text] [Related]
4. Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency. Fukushima K; Yazaki M; Nakamura M; Tanaka N; Kobayashi K; Saheki T; Takei H; Ikeda S Intern Med; 2010; 49(3):243-7. PubMed ID: 20118603 [TBL] [Abstract][Full Text] [Related]
5. A case of adult-onset type II citrullinemia--deterioration of clinical course after infusion of hyperosmotic and high sugar solutions. Takahashi H; Kagawa T; Kobayashi K; Hirabayashi H; Yui M; Begum L; Mine T; Takagi S; Saheki T; Shinohara Y Med Sci Monit; 2006 Feb; 12(2):CS13-5. PubMed ID: 16449956 [TBL] [Abstract][Full Text] [Related]
7. Clinical findings in five Turkish patients with citrin deficiency and identification of a novel mutation on SLC25A13. Köse MD; Kagnici M; Özdemir TR; Erdur CB; Erdemir G; Karakoyun M; Guzin Y; Ceylaner S; Genel F J Pediatr Endocrinol Metab; 2020 Jan; 33(1):157-163. PubMed ID: 31809266 [TBL] [Abstract][Full Text] [Related]
8. A case of adult-onset type II citrullinemia induced by hospital diet. Ueda A; Okada K; Takahara T; Iwasa K; Shinagawa K; Entani A; Inatsuchi S; Ando T; Fujinami H; Tajiri K; Tokimitsu Y; Ogawa K; Miyazono T; Miyazaki T; Murakami J; Hosokawa A; Yasumura S; Minemura M; Kudo T; Sugiyama T Clin J Gastroenterol; 2011 Feb; 4(1):28-33. PubMed ID: 26190618 [TBL] [Abstract][Full Text] [Related]
9. Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2. Okano Y; Ohura T; Sakamoto O; Inui A Mol Genet Metab; 2019 Jul; 127(3):175-183. PubMed ID: 31255436 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). Saheki T; Kobayashi K J Hum Genet; 2002; 47(7):333-41. PubMed ID: 12111366 [TBL] [Abstract][Full Text] [Related]
11. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Saheki T; Kobayashi K; Iijima M; Moriyama M; Yazaki M; Takei Y; Ikeda S Hepatol Res; 2005 Oct; 33(2):181-4. PubMed ID: 16199199 [TBL] [Abstract][Full Text] [Related]
12. Adult-onset type II citrullinemia: Current insights and therapy. Hayasaka K; Numakura C Appl Clin Genet; 2018; 11():163-170. PubMed ID: 30588060 [TBL] [Abstract][Full Text] [Related]
13. [Treatment and Pathomechanism of Citrin Deficiency]. Hayasaka K; Numakura C; Watanabe H Brain Nerve; 2015 Jun; 67(6):739-47. PubMed ID: 26062589 [TBL] [Abstract][Full Text] [Related]
14. [A case of adult-onset type II citrullinemia with repeated nonconvulsive status epilepticus]. Funabe S; Tanaka R; Urabe T; Kawasaki S; Kobayashi K; Hattori N Rinsho Shinkeigaku; 2009 Sep; 49(9):571-5. PubMed ID: 19928687 [TBL] [Abstract][Full Text] [Related]
15. Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia. Sinasac DS; Moriyama M; Jalil MA; Begum L; Li MX; Iijima M; Horiuchi M; Robinson BH; Kobayashi K; Saheki T; Tsui LC Mol Cell Biol; 2004 Jan; 24(2):527-36. PubMed ID: 14701727 [TBL] [Abstract][Full Text] [Related]
16. Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia. Okano Y; Okamoto M; Yazaki M; Inui A; Ohura T; Murayama K; Watanabe Y; Tokuhara D; Takeshima Y Mol Genet Metab; 2021 May; 133(1):63-70. PubMed ID: 33741270 [TBL] [Abstract][Full Text] [Related]
17. The characteristics of food intake in patients with type II citrullinemia. Nakamura M; Yazaki M; Kobayashi Y; Fukushima K; Ikeda S; Kobayashi K; Saheki T; Nakaya Y J Nutr Sci Vitaminol (Tokyo); 2011; 57(3):239-45. PubMed ID: 21908947 [TBL] [Abstract][Full Text] [Related]
18. Hypoglycemic attacks and growth failure are the most common manifestations of citrin deficiency after 1 year of age. Arai-Ichinoi N; Kikuchi A; Wada Y; Sakamoto O; Kure S J Inherit Metab Dis; 2021 Jul; 44(4):838-846. PubMed ID: 33861477 [TBL] [Abstract][Full Text] [Related]
19. Chronic pancreatitis and pancreatic pseudocyst with adult-onset type II citrullinemia. Kakiuchi T; Nakayama A; Akiyama T; Martsuo M Clin J Gastroenterol; 2020 Feb; 13(1):97-101. PubMed ID: 31256334 [TBL] [Abstract][Full Text] [Related]
20. A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. Liu G; Wei X; Chen R; Zhou H; Li X; Sun Y; Xie S; Zhu Q; Qu N; Yang G; Chu Y; Wu H; Lan Z; Wang J; Yang Y; Yi X Gene; 2014 Jan; 533(2):547-53. PubMed ID: 24161253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]